Singapore: ACM Global Central Laboratory, US-based diagnostic central laboratory, has expanded in China with the opening of ACM Shanghai, emerged after acquisition of Phoenix Pharma Central Services, to provide support to clinical trials in and around Shanghai.

"The opening of our wholly-owned Shanghai lab facility follows the successful launch of ACM Singapore in June, further extending ACM Global's network of operating labs in an increasingly important region for clinical research," said Mr Jerry Boxall, managing director, ACM Europe and Asia. "We are thrilled to operate the new Shanghai and Singapore facilities in parallel to our locations in the United States, United Kingdom and India, providing the same robust capabilities and standards in scientific expertise. By seamlessly integrating operations of both new and existing facilities, we've established a network of harmonized laboratories producing a single database of test data for all global projects."

ACM Shanghai is 10,000 square feet in size and located within the Shanghai International Medical Zone of the city's Pudong district. The purpose-designed lab facility houses cutting-edge instruments and equipment identical to ACM's US and UK laboratories and provides a broad menu of safety and specialty testing, including chemistry, hematology, urinalysis, and immunology testing.